Development and commercialization of medical technologies for the treatment of cardiovascular diseases, focusing on intravascular lithotripsy systems.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Balt
B
Development and marketing of neurovascular and peripheral vascular medical devices for stroke treatment and peripheral embolization.
Mölnlycke Health Care France
A
Development and marketing of innovative medical solutions, including hydrocellular dressings, negative pressure therapy systems, and products for operating rooms.
IDMED
B
Development and commercialization of innovative medical devices for anesthesia and intensive care.
Initiatives identified among leaders
Réduction des émissions de gaz à effet de serre
“Mölnlycke Health Care France réduit ses émissions ...” - Mölnlycke Health Care FranceSélectionner des fournisseurs responsables
“IDMED sélectionne des fournisseurs responsables en...” - IDMEDDéfinition de procédures pour la santé et la sécurité au travail
“Balt met en place des procédures pour assurer la s...” - Balt44% of similar organizations communicate on CSR issues
+920 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports